Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease

Clinical and Vaccine Immunology

Volumn 18, Issue 11, 2011, Pages 1850-1855

  De Marchi, Claudia R ^a   Di Noia, Javier M ^b,c   Frasch, Alberto C C ^b   Neto, Vicente Amato ^a   Almeid, Igor C ^a,d   Buscaglia, Carlos A ^b,e  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITY OF TEXAS AT EL PASO   (United States)

^e INSTITUTO NACIONAL DE TECNOLOGÍA INDUSTRIAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; RECOMBINANT PROTEIN; TRYPOMASTIGOTE SMALL SURFACE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIMASTIGOTE; GENE SEQUENCE; HEMAGGLUTINATION TEST; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI;

EID: 80455129029     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05289-11     Document Type: Article

References (36)

1. Agapova, M., M. P. Busch, and B. Custer. 2010. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion 50:2220-2232.
2. Almeida, I. C., et al. 2000. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19:1476-1485. (Pubitemid 30182155)
3. Almeida, I. C., D. T. Covas, L. M. Soussumi, and L. R. Travassos. 1997. A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 37:850-857. (Pubitemid 27369139)
4. Almeida, I. C., M. A. Ferguson, S. Schenkman, and L. R. Travassos. 1994. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas'disease recognize novel O-linked oligosaccharides on mucin-like glycosylphosphatidylinositol- anchored glycoproteins of Trypanosoma cruzi. Biochem. J. 304(Part 3):793-802.
5. Andrade, A. L., et al. 2004. Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. Am. J. Trop. Med. Hyg. 71:594-597. (Pubitemid 39601157)
6. Araujo, F. G. 1986. Analysis of Trypanosoma cruzi antigens bound by specific antibodies and by antibodies to related trypanosomatids. Infect. Immun. 53:179-185. (Pubitemid 16084383)
7. Bhattacharyya, T., et al. 2010. Analysis of molecular diversity of the Trypanosoma cruzi trypomastigote small surface antigen reveals novel epitopes, evidence of positive selection and potential implications for lineage-specific serology. Int. J. Parasitol. 40:921-928.
8. Buscaglia, C. A., et al. 2004. The surface coat of the mammal-dwelling infective trypomastigote stage of Trypanosoma cruzi is formed by highly diverse immunogenic mucins. J. Biol. Chem. 279:15860-15869. (Pubitemid 38509273)
9. Buscaglia, C. A., and J. M. Di Noia. 2003. Trypanosoma cruzi clonal diversity and the epidemiology of Chagas' disease. Microbes Infect. 5:419-427. (Pubitemid 36549184)
10. Camargo, M. E. 1966. Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev. Inst. Med. Trop. Sao Paulo 8:227-235.
11. Coura, J. R., A. C. Junqueira, O. Fernandes, S. A. Valente, and M. A. Miles. 2002. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol. 18: 171-176. (Pubitemid 34606845)
12. da Silveira, J. F., E. S. Umezawa, and A. O. Luquetti. 2001. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol. 17:286-291.
13. de Andrade, A. L., et al. 1996. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348:1407-1413.
14. de Lederkremer, R. M., and R. Agusti. 2009. Glycobiology of Trypanosoma cruzi. Adv. Carbohydr. Chem. Biochem. 62:311-366.
15. Di Noia, J. M., C. A. Buscaglia, C. R. De Marchi, I. C. Almeida, and A. C. Frasch. 2002. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. J. Exp. Med. 195:401-413. (Pubitemid 34461294)
16. Duffy, T., et al. 2009. Accurate real-time PCR strategy for monitoring blood-stream parasitic loads in Chagas disease patients. PLoS Negl. Trop. Dis. 3:e419.
17. El-Sayed, N. M., et al. 2005. Comparative genomics of trypanosomatid parasitic protozoa. Science 309:404-409.
18. Gascon, J., C. Bern, and M. J. Pinazo. 2010. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 115:22-27.
19. Gomes, Y. M., V. M. Lorena, and A. O. Luquetti. 2009. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem. Inst. Oswaldo Cruz 104(Suppl. 1): 115-121.
20. Hernandez Marin, M., I. Hernandez Spengler, G. Ramos Martinez, and L. Pozo Pena. 2006. Chimeric synthetic peptides as antigens for detection of antibodies to Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 339:89-92. (Pubitemid 41697518)
21. Hoshino-Shimizu, S., M. E. Camargo, and E. S. Umezawa. 1975. A rapid slide flocculation test for the diagnosis of American trypanosomiasis using Trypanosoma cruzi fragments preserved by lyophilization. Comparison with hemagglutination, immunofluorescence, and complement fixation tests. Am. J. Trop. Med. Hyg. 24:586-589.
22. Houghton, R. L., et al. 2000. Multiepitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas' disease. J. Infect. Dis. 181:325-330. (Pubitemid 30049064)
23. Leiby, D. A. 2004. Threats to blood safety posed by emerging protozoan pathogens. Vox Sang. 87(Suppl. 2):120-122.
24. Mendoza, V. M., G. A. Kashiwagi, R. M. de Lederkremer, and C. Gallo-Rodriguez. 2010. Synthesis of trisaccharides containing internal galactofuranose O-linked in Trypanosoma cruzi mucins. Carbohydr. Res. 345:385-396.
25. Pastini, A. C., et al. 1994. Immunoassay with recombinant Trypanosoma cruzi antigens potentially useful for screening donated blood and diagnosing Chagas disease. Clin. Chem. 40:1893-1897.
26. Pereira-Chioccola, V. L., et al. 2000. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies. J. Cell Sci. 113(Part 7):1299-1307. (Pubitemid 30229546)
27. Rassi, A., Jr., A. Rassi, and J. A. Marin-Neto. 2010. Chagas disease. Lancet 375:1388-1402.
28. Reithinger, R., R. L. Tarleton, J. A. Urbina, U. Kitron, and R. E. Gurtler. 2009. Eliminating Chagas disease: challenges and a roadmap. BMJ 338: b1283.
29. Risso, M. G., et al. 2011. Immunological identification of Trypanosoma cruzi lineages in human infection along the endemic area. Am. J. Trop. Med. Hyg. 84:78-84.
30. Russomando, G., Z. Sanchez, G. Meza, and Y. de Guillen. 2010. Shed acute-phase antigen protein in an ELISA system for unequivocal diagnosis of congenital Chagas disease. Expert Rev. Mol. Diagn. 10:705-707.
31. Schijman, A. G., et al. 2011. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl. Trop. Dis. 5:e931.
32. Schmunis, G. A., and Z. E. Yadon. 2010. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 115:14-21.
33. Schnaidman, B. B., N. Yoshida, P. A. Gorin, and L. R. Travassos. 1986. Cross-reactive polysaccharides from Trypanosoma cruzi and fungi (especially Dactylium dendroides). J. Protozool. 33:186-191.
34. Vergara, U., et al. 1991. Assay for detection of Trypanosoma cruzi antibodies in human sera based on reaction with synthetic peptides. J. Clin. Microbiol. 29:2034-2037.
35. Yoshida, N. 2009. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Mem. Inst. Oswaldo Cruz 104(Suppl. 1):101-107.
36. Zingales, B., et al. 2009. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz 104:1051-1054.